AI
Tuesday, September 29, 2020 1:48:24 PM
The FDA has progressed with $NBIO’s Investigational New Drug application, allowing the Company to set up for a phase one clinical trials. Once the application is approved, the company will likely move immediately to kick off that trial. https://biopharmajournal.com/2020/09/29/why-nascent-biotech-inc-otcmktsnbio-is-worth-a-close-look
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
